Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

• Autori principali: Nakamura T (Autore), Kubota T (Autore), Iwakaji A (Autore), Imada M (Autore), Kapás M (Autore), Morio Y (Autore)
• Natura: Libro
• Pubblicazione: Dove Medical Press, 2016-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Tadakatsu Nakamura,1 Tomoko Kubota,1 Atsushi Iwakaji,1 Masayoshi Imada,1 Margit Kapás,2 Yasunori Morio1 1Sohyaku. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan; 2Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary Purpose: Cari...